Results 131 to 140 of about 22,145 (200)

KLRG1 silencing increases the efficacy of CAR NK cell therapy against colon cancer via SHP-2/ZAP-70/NF-κB signal pathway. [PDF]

J Transl Med
Chen Y, Farooq MA, Hui X, Huang Y, Hu Y, Xue M, Ajmal I, Ren Y, Ji Y, Wang C, Jiang W.   +10 more
europepmc   +1 more source

NK cell hyperactivation drives macrophage repolarization and limits M2 bias in pemphigus vulgaris. [PDF]

Front Immunol
Hooda V, Singh A, Khandpur S, Arava S, Madan T, Sharma A.   +5 more
europepmc   +1 more source

E3 ubiquitin ligase NKLAM/RNF19b suppresses myc-driven B cell lymphomagenesis in Eμ-myc mice. [PDF]

Front Oncol
Hoover RG, Matchett EC, Kornbluth J.
europepmc   +1 more source

[Research progress of the ULBP-NKG2D axis in autoimmune diseases]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Ma J, Wu J, Jin Y.
europepmc   +1 more source

MICA-129Met/Val as a therapeutic compass in idiopathic pulmonary fibrosis: prognosis and antifibrotic benefit. [PDF]

Front Immunol
Mocci S, Mereu C, Littera R, Deidda S, Cannas F, Lorrai M, Zedda E, Murgia M, Sanna C, Giuressi E, Lai S, Perra A, Floris M, Giglio S.   +13 more
europepmc   +1 more source

Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancer. [PDF]

J Biol Eng
Lee SG, Lee M, Lee HM, Son GH, Yoon SR, Chae BH, Kim DS, Lee KM, Kim YS.   +8 more
europepmc   +1 more source

Immune Evasion Strategies of Human Poxviruses: A Roadmap for Engineering Low-Immunogenic CAR-Based and iPSC-Derived Cell Products. [PDF]

Cells
Antonov DO, Loguinova MY, Fan H, Sazonova EV, Sosnovtseva AO, Karpov DS, Molchanov AD, Nikolenko VN, Chekhonin VP, Mokrysheva NG.   +9 more
europepmc   +1 more source

Cetuximab combination with cytokine induced killer cells effectively inhibit conjunctival squamous cell carcinoma in vitro. [PDF]

BMC Immunol
Aghaei H, Khakpour M, Dehghan S, Ghamari A, Shoae-Hassani A.   +4 more
europepmc   +1 more source